About Sun Pharma

Sun Pharma is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company. A vertically integrated business, economies of scale and an extremely skilled team enable us to deliver quality products in a timely manner at affordable prices. It provides high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma’s global presence is supported by 44 manufacturing facilities spread across 6 continents, R&D centres across the globe and a multi-cultural workforce comprising over 50 nationalities. In India, the company enjoys leadership across 10 different classes of doctors with 30 brands featuring amongst top 300 pharmaceutical brands in India. Its footprint across emerging markets covers over 100 markets and 6 markets in Western Europe. Its Global Consumer Healthcare business is ranked amongst Top 10 across 3 global markets. Its API business footprint is strengthened through 14 world class API manufacturing facilities across the globe. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising about 2,000 scientists and R&D investments of approximately 7% of annual revenues.

For further information, please visit www.sunpharma.com & follow us on Twitter @SunPharma_Live.

Sun Pharma Morocco

About Sun Pharmaceuticals Morocco LLC

We are one of the fastest growing pharmaceutical companies in Morocco and currently market 19 brands across the anti-infective, neuro-psychiatry, cardiovascular, urology and critical care therapeutic areas. We were the first generic company in Morocco to launch Cefuroxime Axetil, Imipenem + Cilastatin, Alfuzosin MR, Once Daily Ofloxacin, Donepezil, Monteleukast and Mycophenolate Moferil. Some of our leading brands are Ceroxim, Flotral, Nupentin, Dopezil and Bacqure. We are a key supplier of anti-retroviral (ARV) drugs to the HIV/AIDS Treatment Programme of the Ministry of Health. We started our manufacturing operations in Casablanca in March 2012.